YntraDose is killing human tumors, something MK has completely failed at after almost a decade of running RDGL. And there's nothing stopping Betaglue from using dispersed Y90 like RDGL does. They must have a good reason for using the encapsulated Y90. Maybe much easier to get regulatory approval with that approach? Again, Betaglue has competent management and RDGL doesn't. Facts are facts.
Market Data 
Markets 
AI
